#BEGIN_DRUGCARD DB04438

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H14BrN2O8P

# Chemical_IUPAC_Name:
{[(2S,3R,5R)-5-{5-[(E)-2-bromoethenyl]-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl}-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
BVDU-MP

# HET_ID:
BVP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H14BrN2O8P/c12-2-1-6-4-14(11(17)13-10(6)16)9-3-7(15)8(22-9)5-21-23(18,19)20/h1-2,4,7-9,15H,3,5H2,(H,13,16,17)(H2,18,19,20)/b2-1+/t7-,8+,9-/m1/s1

# InChI_Key:
InChIKey=LKWCVKAHHUJPQO-UDGIAEMFSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4438

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
413.115

# Molecular_Weight_Mono:
411.967114593

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1OSN

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.76

# Predicted_LogS:
-2

# Predicted_Water_Solubility:
3.97e+00 g/l

# Primary_Accession_No:
DB04438

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936977

# PubChem_Substance_ID:
46507968

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00784

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
Br\C=C\C1=CN(C(=O)NC1=O)[C@H]1C[C@@H](O)[C@H](COP(O)(O)=O)O1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
BVP

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:19 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
12686543	Bird LE, Ren J, Wright A, Leslie KD, Degreve B, Balzarini J, Stammers DK: Crystal structure of varicella zoster virus thymidine kinase. J Biol Chem. 2003 Jul 4;278(27):24680-7. Epub 2003 Apr 9.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M36160

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ORF36

# Drug_Target_1_Gene_Sequence:
>1026 bp
ATGTCAACGGATAAAACCGATGTAAAAATGGGCGTTTTGCGTATTTATTTGGACGGGGCG
TATGGAATTGGAAAAACAACCGCCGCCGAAGAATTTTTACACCACTTTGCAATAACACCA
AACCGGATCTTACTCATTGGGGAGCCCCTGTCGTATTGGCGTAACCTTGCAGGGGAGGAC
GCTATTTGCGGAATTTACGGAACACAAACTCGCCGTCTTAATGGAGACGTTTCGCCTGAA
GACGCACAACGCCTCACGGCTCATTTTCAGAGCCTGTTCTGTTCTCCGCATGCAATTATG
CATGCGAAAATCTCGGCATTGATGGACACAAGTACATCGGATCTCGTACAAGTAAATAAG
GAGCCGTATAAAATTATGTTATCCGACCGACACCCAATCGCCTCAACTATATGTTTTCCC
TTGTCCAGATACTTAGTGGGAGATATGTCCCCAGCGGCGCTTCCTGGGTTATTGTTTACG
CTTCCCGCTGAACCCCCCGGGACCAACTTGGTAGTTTGTACCGTTTCACTCCCCAGTCAT
TTATCCAGAGTAAGCAAACGGGCCAGACCGGGAGAAACGGTTAATCTGCCGTTTGTTATG
GTTCTGAGAAATGTATATATAATGCTTATTAATACAATTATATTTCTTAAAACTAACAAC
TGGCACGCGGGCTGGAACACACTGTCATTTTGTAATGATGTATTTAAACAGAAATTACAA
AAATCCGAGTGTATAAAACTACGCGAAGTACCTGGGATTGAAGACACGTTATTCGCCGTN
CTTAAACTTCCGGAGCTTTGCGGAGAGTTTGGAAATATTCTGCCGTTATGGGCATGGGGA
ATGGAGACCCTTTCAAACTGCTTACGAAGCATGTCTCCGTTCGTATTATCGTTAGAACAG
ACACCCCAGCATGCGGCACAAGAACTAAAAACTCTGCTACCCCAGATGACCCCGGCAAAC
ATGTCCTCCGGTGCATGGAATATATTGAAAGAGCTTGTTAATGCCGTTCAGGACAACACT
TCCTAA

# Drug_Target_1_General_Function:
Involved in thymidine kinase activity

# Drug_Target_1_General_References:
1848597	Lacey SF, Suzutani T, Powell KL, Purifoy DJ, Honess RW: Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. J Gen Virol. 1991 Mar;72 ( Pt 3):623-30.
2844967	Sawyer MH, Inchauspe G, Biron KK, Waters DJ, Straus SE, Ostrove JM: Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. J Gen Virol. 1988 Oct;69 ( Pt 10):2585-93.
2852653	Mori H, Shiraki K, Kato T, Hayakawa Y, Yamanishi K, Takahashi M: Molecular analysis of the thymidine kinase gene of thymidine kinase-deficient mutants of varicella-zoster virus. Intervirology. 1988;29(6):301-10.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5771

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
37843

# Drug_Target_1_Name:
Thymidine kinase

# Drug_Target_1_Number_of_Residues:
341

# Drug_Target_1_PDB_ID:
1OSN

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00693	Herpes_TK

# Drug_Target_1_Protein_Sequence:
>Thymidine kinase
MSTDKTDVKMGVLRIYLDGAYGIGKTTAAEEFLHHFAITPNRILLIGEPLSYWRNLAGED
AICGIYGTQTRRLNGDVSPEDAQRLTAHFQSLFCSPHAIMHAKISALMDTSTSDLVQVNK
EPYKIMLSDRHPIASTICFPLSRYLVGDMSPAALPGLLFTLPAEPPGTNLVVCTVSLPSH
LSRVSKRARPGETVNLPFVMVLRNVYIMLINTIIFLKTNNWHAGWNTLSFCNDVFKQKLQ
KSECIKLREVPGIEDTLFAVLKLPELCGEFGNILPLWAWGMETLSNCLRSMSPFVLSLEQ
TPQHAAQELKTLLPQMTPANMSSGAWNILKELVNAVQDNTS

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ATP + thymidine = ADP + thymidine 5'- phosphate

# Drug_Target_1_SwissProt_ID:
P0C0E6

# Drug_Target_1_SwissProt_Name:
KITH_VZVO

# Drug_Target_1_Synonyms:
EC 2.7.1.21

# Drug_Target_1_Theoretical_pI:
7.22

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04438
